Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus...

por Shinn, Brianna J, Martin, Aaron, Coben, Robert M, Conn, Mitchell I, Prieto, Jorge, Kroop, Howard, DiMarino, Anthony J, Hann, Hie-Won
Publicado 2019